155 related articles for article (PubMed ID: 9846611)
1. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum.
McManus DP; Liu S; Song G; Xu Y; Wong JM
Int J Parasitol; 1998 Nov; 28(11):1739-42. PubMed ID: 9846611
[TBL] [Abstract][Full Text] [Related]
2. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum.
Ramirez BL; Kurtis JD; Wiest PM; Arias P; Aligui F; Acosta L; Peters P; Olds GR
Parasite Immunol; 1996 Jan; 18(1):49-52. PubMed ID: 9223156
[TBL] [Abstract][Full Text] [Related]
3. A vaccine against the Asian schistosome, Schistosoma japonicum: an update on paramyosin as a target of protective immunity.
Kalinna BH; McManus DP
Int J Parasitol; 1997 Oct; 27(10):1213-9. PubMed ID: 9394192
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of Schistosoma japonicum paramyosin induced robust long-lasting systemic and local antibody as well as delayed-type hypersensitivity responses, but failed to confer protection in a mouse infection model.
Kohama H; Harakuni T; Kikuchi M; Nara T; Takemura Y; Miyata T; Sato Y; Hirayama K; Arakawa T
Jpn J Infect Dis; 2010 May; 63(3):166-72. PubMed ID: 20495267
[TBL] [Abstract][Full Text] [Related]
5. Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice.
Zhang DM; Pan WQ; Qian L; Duke M; Shen LH; McManus DP
Parasite Immunol; 2006 Mar; 28(3):77-84. PubMed ID: 16441505
[TBL] [Abstract][Full Text] [Related]
6. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes.
McManus DP; Wong JY; Zhou J; Cai C; Zeng Q; Smyth D; Li Y; Kalinna BH; Duke MJ; Yi X
Vaccine; 2001 Dec; 20(5-6):870-8. PubMed ID: 11738752
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccination of mice with recombinant Schistosoma japonicum proteins induces specific anti-parasite antibodies and damage to adult worms after a challenge infection.
Yang W; Gobert GN; McManus DP
Int J Parasitol; 1997 Jul; 27(7):843-53. PubMed ID: 9279589
[TBL] [Abstract][Full Text] [Related]
8. Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica.
Jiz M; Wu HW; Meng R; Pond-Tor S; Reynolds M; Friedman JF; Olveda R; Acosta L; Kurtis JD
Infect Immun; 2008 Jul; 76(7):3164-9. PubMed ID: 18426875
[TBL] [Abstract][Full Text] [Related]
9. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host.
Taylor MG; Huggins MC; Shi F; Lin J; Tian E; Ye P; Shen W; Qian CG; Lin BF; Bickle QD
Vaccine; 1998 Aug; 16(13):1290-8. PubMed ID: 9682393
[TBL] [Abstract][Full Text] [Related]
10. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes.
Waine GJ; Yang W; Scott JC; McManus DP; Kalinna BH
Vaccine; 1997 Jun; 15(8):846-8. PubMed ID: 9234530
[TBL] [Abstract][Full Text] [Related]
11. Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum.
Liu S; Song G; Xu Y; Yang W; McManus DP
Vaccine; 1995 Apr; 13(6):603-7. PubMed ID: 7483782
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12.
Zhu Y; Ren J; Da'dara A; Harn D; Xu M; Si J; Yu C; Liang Y; Ye P; Yin X; He W; Xu Y; Cao G; Hua W
Vaccine; 2004 Nov; 23(1):78-83. PubMed ID: 15519710
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of domestic pig with recombinant paramyosin. against Schistosoma japonicum in China.
Chen H; Nara T; Zeng X; Satoh M; Wu G; Jiang W; Yi F; Kojima S; Zhang S; Hirayama K
Vaccine; 2000 Apr; 18(20):2142-6. PubMed ID: 10715529
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.
Wu HW; Fu ZQ; Lu K; Pond-Tor S; Meng R; Hong Y; Chu K; Li H; Jiz M; Liu JM; Hou M; Park S; Lin JJ; Kurtis JD
Vaccine; 2017 Jun; 35(26):3409-3415. PubMed ID: 28504194
[TBL] [Abstract][Full Text] [Related]
15. Update on paramyosin in parasitic worms.
Gobert GN; McManus DP
Parasitol Int; 2005 Jun; 54(2):101-7. PubMed ID: 15866471
[TBL] [Abstract][Full Text] [Related]
16. Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target.
Zhang W; Li J; Duke M; Jones MK; Kuang L; Zhang J; Blair D; Li Y; McManus DP
PLoS Negl Trop Dis; 2011; 5(5):e1166. PubMed ID: 21655308
[TBL] [Abstract][Full Text] [Related]
17. Mechanism by which the combination of SjCL3 and SjGAPDH protects against Schistosoma japonicum infection.
Huang W; Gu M; Cheng W; Wang S; Li K; Zhao QP; Ming Z; Dong H
Parasitol Res; 2021 Jan; 120(1):173-185. PubMed ID: 33079271
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4
Tang CL; Yang J; Cheng LY; Cheng LF; Liu ZM
Parasitol Res; 2017 Oct; 116(10):2727-2732. PubMed ID: 28825137
[TBL] [Abstract][Full Text] [Related]
19. A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens.
Xu X; Zhang D; Sun W; Zhang Q; Zhang J; Xue X; Shen L; Pan W
BMC Infect Dis; 2009 May; 9():54. PubMed ID: 19419545
[TBL] [Abstract][Full Text] [Related]
20. Cloning and partial nucleotide sequence of Schistosoma japonicum paramyosin: a potential vaccine candidate against schistosomiasis.
Yang W; Waine GJ; Sculley DG; Liu X; McManus DP
Int J Parasitol; 1992 Dec; 22(8):1187-91. PubMed ID: 1487380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]